興科蓉醫藥：年報2023.pdf

1、2023 ANNUAL REPORT 年報Contents 目錄2Corporate Information公司資料4Financial Highlights財務摘要6Chairmans Statement主席報告9Management Discussion and Analysis管理層討論及分析27Directors and Senior Management董事及高級管理層34Report of the Directors董事會報告51Corporate Governance Report企業管治報告74Independent Auditors Report獨立核數師報告81Consol

2、idated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表82Consolidated Statement of Financial Position綜合財務狀況表84Consolidated Statement of Changes in Equity綜合權益變動表85Consolidated Statement of Cash Flows綜合現金流量表88Notes to the Consolidated Financial Statements綜合財務報表附註190Definitions釋義2

3、Sinco Pharmaceuticals Holdings LimitedAnnual Report 2023Corporate Information公司資料BOARD OF DIRECTORSExecutive DirectorsMr.Huang Xiangbin(Chairman)Mr.Lei Shifeng(appointed with effect from 29 March 2023)Mr.Huang Zhijian(appointed with effect from 26 March 2024)Independent Non-executive DirectorsMr.Lau

4、 Ying KitMr.Liu WenfangMr.Wang QingMr.Bai ZhizhongAUDIT COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Liu WenfangMr.Wang QingMr.Bai ZhizhongREMUNERATION COMMITTEEMr.Wang Qing(Chairman)Mr.Liu WenfangMr.Bai ZhizhongMr.Lei Shifeng(appointed with effect from 29 March 2023)NOMINATION COMMITTEEMr.Huang Xiangbin(Ch

5、airman)Mr.Liu WenfangMr.Lau Ying KitINTERNAL CONTROL AND CORPORATE GOVERNANCE COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Wang QingMr.Liu WenfangMr.Bai ZhizhongMr.Lei Shifeng(appointed with effect from 29 March 2023)AUTHORISED REPRESENTATIVESMr.Huang XiangbinMr.Li Kin Wai(resigned with effect from 26 March

6、 2024)Ms.Peng Yunlu(appointed with effect from 26 March 2024)COMPANY SECRETARIESMs.Peng YunluMr.Li Kin Wai(resigned with effect from 26 March 2024)REGISTERED OFFICEPO Box 309Ugland HouseGrand Cayman,KY1-1104Cayman Islands董事會執行董事黃祥彬先生（主席）雷世鋒先生（於2023年3月29日獲委任）黃智健先生（於2024年3月26日獲委任）獨立非執行董事劉英傑先生劉文芳先生汪晴先生